Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;12(6 Suppl 3):S161-S163.
doi: 10.5489/cuaj.5325.

Management of chronic prostatitis/chronic pelvic pain syndrome

Affiliations
Review

Management of chronic prostatitis/chronic pelvic pain syndrome

R Christopher Doiron et al. Can Urol Assoc J. 2018 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Nickel has been a consultant for Astellas, Auxillium, Eli Lilly, Farr Labs, Ferring, GSK, Pfizer, Redleaf Pharma, Taris Biomedical, Tribute, and Trillium Therapeutics; a lecturer for Astellas and Eli Lilly; and has participated in clinical trials supported by Eli Lilly, GSK, J&J, Pfizer, and Taris Biomedical. Dr. Doiron reports no competing personal or financial conflicts related to this work.

Figures

Fig. 1
Fig. 1
A multimodal approach to treatment, directed at specific symptom patterns, organized here using the UPOINT phenotype approach. ABx: antibiotic; BPH: benign prostatic hyperplasia; CBT: cognitive behavioural therapy; PDE-5i: phosphodiesterase type 5 inhibitor; UTI: urinary tract infection; 5-ARI: 5α-reductase inhibitors.

References

    1. Nickel JC. Prostatitis. Can Urol Assoc J. 2011;5:306–15. doi: 10.5489/cuaj.686. - DOI - PMC - PubMed
    1. Engeler D, Baranowski AP, Borovicka J, et al. Pocket Guidelines, 2017 Edition. European Association of Urology; 2017. EAU guidelines on chronic pelvic pain; pp. 352–374.
    1. Nickel JC, Shoskes DA, Wagenlehner FME. Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): The studies, the evidence, and the impact. World J Urol. 2013;31:747–53. doi: 10.1007/s00345-013-1062-y. - DOI - PubMed

LinkOut - more resources